Mylan (MYL +1.4%) has pulled out of discussions to buy a stake in Italian pharmaceutical firm...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL +1.4%) has pulled out of discussions to buy a stake in Italian pharmaceutical firm Rottapharm after the selling family wouldn't agree to give up control, nor compromise enough on price. Rottapharm has also held talks with Watson Pharmaceuticals (WPI -0.2%) and Forest Labs (FRX +0.1%), however Watson doesn't appear likely to be a buyer.